STOCK TITAN

PHARMAGREEN BIOTECH (PHBI) Stock Price, News & Analysis

PHBI OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
107 234 sessions, August 11, 2025 to August 11, 2026
Largest daily move
-56.2% close of May 18, 2026
1-year change
-50% closing prices, August 11, 2025 to August 11, 2026
1-month change
-44.4% closing prices, July 8, 2026 to August 11, 2026

Company Description

PHARMAGREEN BIOTECH (OTC: PHBI) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $570.7K.

PHBI has declined 50.0% over the past year. The last closing price was $1.00.

For FY2022, PHARMAGREEN BIOTECH reported net income of -$876K.

This page collects what Stock Titan holds for PHBI, including price data, latest news, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-50%
Performance 1 year
$570.7K

PHARMAGREEN BIOTECH (PHBI) closed at $1.00 on August 11, 2026. Over the past 12 months, the price has lost 50.0%.

See what a $1,000 investment in PHBI would be worth today

PHBI Metrics & Rankings

Price returns through August 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

PHARMAGREEN BIOTECH has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, acquisition. View all PHBI news →

SEC Filings

No SEC filings available for PHBI.

Financial Highlights

net income was -$876K. The company generated -$427K in operating cash flow. The current ratio was 0.11, measuring current assets divided by current liabilities.

-$876K
Net Income (FY2022)
-$427K
Operating Cash Flow
—
Revenue (FY2022)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in PHARMAGREEN BIOTECH (PHBI) currently stands at 197.2 thousand shares, down 65.1% from the previous reporting period. Since October 2025, short interest has increased by 1351.9%.

Days to Cover History

Last 12 Months

Days to cover for PHARMAGREEN BIOTECH (PHBI) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

PHBI Company Profile & Sector Positioning

PHARMAGREEN BIOTECH (PHBI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing PHBI often look at related companies in the same sector, including GOLD RIVER PRODS INC (GRPS), VIBE GROWTH CORP (VIBEF), MAPLE LEAF GREEN WRLD INC (MGWFF), LIVEWIRE ERGOGENICS INC (LVVV), and NUTRA PHARMA CORP (NPHC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PHBI's relative position within its industry.

Frequently Asked Questions

What is the current stock price of PHARMAGREEN BIOTECH (PHBI)?

The current stock price of PHARMAGREEN BIOTECH (PHBI) is $1 as of August 11, 2026.

What is the market cap of PHARMAGREEN BIOTECH (PHBI)?

The market cap of PHARMAGREEN BIOTECH (PHBI) is approximately $570.7K. Learn more about what market capitalization means .

What is the net income of PHARMAGREEN BIOTECH (PHBI)?

The FY2022 net income of PHARMAGREEN BIOTECH (PHBI) is -$876K, from its most recent completed fiscal year.

What is the operating cash flow of PHARMAGREEN BIOTECH (PHBI)?

The operating cash flow of PHARMAGREEN BIOTECH (PHBI) is -$427K. Learn about cash flow.

What is the current ratio of PHARMAGREEN BIOTECH (PHBI)?

The current ratio of PHARMAGREEN BIOTECH (PHBI) is 0.11, measuring current assets divided by current liabilities. Learn about liquidity ratios.